Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > Licensing agreement?

<< Previous

Bullboard Posts

Next >>

Comment by Ciaoon Nov 08, 2022 7:53am

159 Views

Post# 35081258

RE:RE:RE:RE:RE:RE:RE:RE:RE:Licensing agreement?

I believe your previous numbers were off.
https://stockhouse.com/companies/bullboard/v.czo/ceapro-inc?postid=34895122

The presentation slides call for a 50L plant in 2024. As noted in yesterday's NR this can be internally funded. Which webcast did Gilles mention the $100M NPV, I'll need to view again.

I'm thinking $4M takes them to 50L and perhaps up to 100L. 10X that best case is 1000L and that is the holy grail where a $40M plant was needed.

prophetoffactz wrote: "The PGX demo plant should be at 10L. Scaling up 5 to 10 X takes it to 50 to 100 L which is adequate for commercial production."

How many L was the previous $100 million NPV based on?

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario